Clinical highlights from the 2025 MR-Linac Consortium meeting

Session 1:

4 Dec 2025 15:00 GMT

Thursday, 04 December 2025 3:00 PM GMT

Thursday, 04 December 2025 4:00 PM Europe/Warsaw

 

Session 2:

5 Dec 2025 03:00 GMT

Friday, 05 December 2025 3:00 AM GMT

Friday, 05 December 2025 4:00 AM Europe/Warsaw

Overview

Get up to date with the latest clinical trends and advancements in MR-guided radiotherapy (MRgRT), directly from the experts who were there.

Highlights include:

  • Overview and latest clinical results of ongoing MRgRT trials
  • Insights into established clinical workflows on Elekta Unity
  • A look into the future of MRgRT with curative-intent Direct-to-MR-Linac workflows

 

Meet our speaker

 

Highlights of the 20th MR-Linac Consortium meeting

Veronica Dell‘Acqua, MD
Elekta

 

Adaptive 5-fraction radiotherapy for glioblastoma: A comparative analysis of clinical efficacy and patient burden

Zabi Wardak, MD
UT Southwestern Medical Center, Dallas, USA

 

Safety and efficacy of unresectable malignant cardiac tumors treated with concurrent chemoradiation therapy

Prof. Hui Liu, MD
Sun Yat-sen University Cancer Center, China

 

Erectile function preservation with neurovascular-sparing MRgRT for localized prostate cancer: preliminary results of the ERECT trial after 18 months follow-up

Tariq Lalmahomed, MD
UMC Utrecht, The Netherlands

 

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan

Tomas Janssen, PhD
NKI/AvL, The Netherlands

 

Register now

Required fields are marked with asterisk (*)

By clicking the Submit button below you agree to the Elekta Privacy Policy

Footer Dropdowns Footer Dropdowns Matomo End Matomo Code Accessible Form Label